Literature DB >> 16320729

Autoimmune hepatitis and multiple sclerosis: a coincidental association?

J de Seze1, V Canva-Delcambre, I Fajardy, S Delalande, T Stojkovic, E Godet, P Vermersch.   

Abstract

In the present study we report, as part of a large multiple sclerosis (MS) cohort (1800 patients), three cases of untreated patients who developed autoimmune hepatitis (AIH). The prevalence of AIH in the general population is about 0.0169% and seems to be higher in our MS cohort (0.17%). We suggest that a liver biopsy should systematically be performed in untreated MS patients with a sustained increase of liver enzyme.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16320729     DOI： 10.1191/1352458505ms1239oa

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


  11 in total

1.  Glatiramer acetate induced acute exacerbation of autoimmune hepatitis in a patient with multiple sclerosis.

Authors:  Helmut Neumann; Antal Csepregi; Michael Sailer; Peter Malfertheiner
Journal:  J Neurol       Date:  2007-03-12       Impact factor: 4.849

2.  Development of autoimmune hepatitis type 1 after pulsed methylprednisolone therapy for multiple sclerosis: a case report.

Authors:  Atsushi Takahashi; Yukiko Kanno; Yuta Takahashi; Natsumi Sakamoto; Kyoko Monoe; Hironobu Saito; Kazumichi Abe; Junko Yokokawa; Atsushi Irisawa; Hiromasa Ohira
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

3.  Autoimmune hepatitis induced by a single injection of interferon-β 1a in a patient with multiple sclerosis.

Authors:  Hiroki Yamaguchi; Kenji Sakai; Yoshinori Goto; Masahito Yamada
Journal:  J Neurol       Date:  2018-05-29       Impact factor: 4.849

Review 4.  A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis.

Authors:  Ruth Ann Marrie; Nadia Reider; Jeffrey Cohen; Olaf Stuve; Per S Sorensen; Gary Cutter; Stephen C Reingold; Maria Trojano
Journal:  Mult Scler       Date:  2014-12-22       Impact factor: 6.312

5.  Autoimmune hepatitis with multiple sclerosis and graves disease: coincidence or association?

Authors:  Omar N Nadhem; Mohammed Al Janabi; Abdel Rahman Omer; Bang Wan
Journal:  Case Rep Gastroenterol       Date:  2014-10-08

Review 6.  A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview.

Authors:  Ruth Ann Marrie; Jeffrey Cohen; Olaf Stuve; Maria Trojano; Per Soelberg Sørensen; Stephen Reingold; Gary Cutter; Nadia Reider
Journal:  Mult Scler       Date:  2015-01-26       Impact factor: 6.312

Review 7.  Liver injury and glatiramer acetate, an uncommon association: case report and literature review.

Authors:  Javier Almeida; Nuria Solà-Valls; Elisa Pose; Yolanda Blanco; María Sepúlveda; Sara Llufriu; Pere Gines; Albert Saiz
Journal:  Ther Adv Neurol Disord       Date:  2017-07-26       Impact factor: 6.570

8.  An Autopsy Case of Fulminant Hepatitis in a Patient with Multiple Sclerosis Treated by Interferon-Beta-1a.

Authors:  Yuichi Yamazaki; Aya Suzuki; Kimitoshi Hirayanagi; Yusuke Tsukagoshi; Ryota Uehara; Kazuhiko Horiguchi; Tatsuya Ohyama; Takuya Tomaru; Norio Horiguchi; Sumihito Nobusawa; Hayato Ikota; Ken Sato; Satoru Kakizaki; Motoyasu Kusano; Yoshio Ikeda; Hideaki Yokoo; Masanobu Yamada
Journal:  Intern Med       Date:  2017-07-15       Impact factor: 1.271

9.  A comprehensive analysis of antigen-specific autoimmune liver disease related autoantibodies in patients with multiple sclerosis.

Authors:  Zisis Tsouris; Christos Liaskos; Efthymios Dardiotis; Thomas Scheper; Vana Tsimourtou; Wolfgang Meyer; George Hadjigeorgiou; Dimitrios P Bogdanos
Journal:  Auto Immun Highlights       Date:  2020-04-10

10.  Vitamin D supplementation for the prevention or depletion of side effects of therapy with alemtuzumab in multiple sclerosis.

Authors:  Hans-Klaus Goischke
Journal:  Ther Clin Risk Manag       Date:  2019-07-12       Impact factor: 2.423
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.